ASML Holding N.V.

ASML Holding N.V. (Ticker: ASML, trading currency: USD)

Conclusion: ASML’s economic engine is still strengthening. This is one of the rare industrial businesses with near-monopoly economics at the most valuable bottleneck in its customers’ value chain.

ASML makes money by selling lithography systems used to print circuits onto wafers, then monetizing that installed base for years through service, maintenance, software, and productivity upgrades. The DNA is simple: sell extremely expensive, mission-critical tools into a tiny customer set, then earn recurring revenue as those tools stay in production. EUV is the crown jewel; at the leading edge, customers effectively cannot compete without it. That gives ASML unusual pricing power, high switching costs, and deep customer entrenchment.

The business is headed up, not down. The latest official data show Q2 2026 net sales of 9300000000 euros, with management raising 2026 total net sales guidance to 43000000000 to 45000000000 euros and guiding to gross margin of 54% to 56%. That matters more than quarter-to-quarter lumpiness: customers are still building around more lithography intensity per wafer, AI demand is pulling forward advanced logic investment, and High NA EUV extends the franchise rather than replacing it.

This is mostly a win-win model. ASML is expensive, but it creates far more value for customers than it extracts: better transistor density, lower power, higher performance, and continued roadmap progress. Customers grumble about capex, but they still need ASML to stay relevant.

I do not see structural deterioration yet. Risks are real: customer concentration, export controls, memory cyclicality, and periodic softness in mature-node DUV. But those are volatility risks, not clear signs of obsolescence or churn. If this business weakens, you would first see it in falling EUV adoption, weaker service mix, lower gross margins, and shrinking leading-edge customer capex. For now, those indicators still point the right way.

The few numbers that matter most: EUV system demand, installed base/service revenue, gross margin, backlog/bookings quality, and customer advanced-node capex.

Conclusion: ASML’s market is a long-duration tailwind. It sells into the most bottlenecked layer of semiconductor manufacturing, where rising compute intensity, AI, advanced packaging, and device complexity all increase lithography content per wafer.

This is not a broad, fragmented equipment market for ASML; it is the strategic choke point of advanced logic and memory. That makes TAM less about unit count and more about rising lithography intensity, node transitions, and installed-base monetization. Near-term semi cycles will stay lumpy, but structurally the market is getting better, not worse. Latest official data used here runs through Q2 2026.

Conclusion: ASML has an exceptional moat, and at the leading edge it is still widening. The core advantage is not “brand”; it is a chokepoint built on EUV/High-NA lithography, decades of accumulated process know-how, and a supplier/customer ecosystem that is almost impossible to recreate.

Recent evidence still points the right way: ASML reported €9.3 billion Q2 2026 sales and raised 2026 guidance to €43-45 billion with 54-56% gross margin, which is what monopoly-like economics look like even in a cyclical industry. The only real caveat: this moat is strongest in leading-edge EUV/High-NA; older DUV layers are less exclusive. Export controls and cycle swings are noise, not moat erosion.

Financial Strength

Conclusion: ASML’s financial strength is elite. The business earns returns that are far above its cost of capital, carries debt from a position of choice rather than necessity, and has enough balance-sheet resilience to ride out a semiconductor downturn without threatening the franchise.

ROE and ROIC have been persistently exceptional for years, which is what you would expect from a near-monopoly tool supplier with high gross margins, service revenue, and customer-funded demand visibility. Debt does not look like survival financing: ASML has historically run with ample cash, strong free cash flow, and modest leverage relative to earnings power. Even in a severe downturn, the combination of cash, profitable service activity, and the strategic indispensability of its tools should keep debt service very manageable.

Earnings quality is strong, not perfect. Cash conversion is good over multi-year periods, but quarterly FCF can swing because EUV/High-NA systems are huge-ticket items with long build cycles, customer acceptance timing, and working-capital lumpiness. The main watch items are customer concentration and inventory/receivables growth during capacity ramps; neither looks like a red flag today. No obvious auditor, revenue-recognition, or related-party warning signs stand out.

Conclusion: ASML still has a long reinvestment runway, but it is narrower than the moat is wide. The best uses of capital remain obvious: fund EUV/High-NA R&D, expand supply-chain capacity, and deepen the service/software annuity around the installed base. Those uses should keep earning very high returns because they strengthen the only credible path to leading-edge lithography.

The key nuance is that growth has already pulled forward. Management’s older 2030 revenue opportunity was EUR 44000000000-EUR 60000000000; by Q2 2026 it raised full-year 2026 sales guidance to EUR 43000000000-EUR 45000000000. So the runway is less about raw unit growth now and more about mix: High-NA adoption, rising lithography intensity per wafer, and higher recurring service content.

Accounting ROIIC is hard to measure cleanly because ASML’s most important reinvestment - R&D - is expensed, not capitalized. Economically, incremental returns still look elite. Historically, management has mostly done the right thing: reinvest first, avoid large empire-building M&A, then return surplus cash.

ASML has no meaningful domestic peer; its real competition is global, and at the leading edge it is still the clear winner. The closest “peers” split into two buckets: direct lithography rivals (Nikon, Canon) and adjacent WFE leaders (Applied, Lam, KLA). The first group matters for mature-node DUV; the second competes for semiconductor capex, not for ASML’s core EUV position.

Most recent official data used: FY2025 filings for ASML and Applied.

ASML is gaining strategic share even if quarterly WFE mix moves around. The driver is simple: advanced-node customers cannot ship frontier logic or memory at scale without ASML’s EUV roadmap, while its service/software revenue deepens switching costs. Outlook: ASML should keep widening its moat at the high end; the only softer flank is mature-node DUV, where pricing is less extraordinary and China localization is the long-tail risk. The business deserves a premium; the stock may not.

Conclusion: aligned, but not owner-operated. ASML’s governance looks shareholder-friendly for a large European public company: no controlling shareholder, a formal two-tier board, disciplined disclosure, and a long record of returning excess cash through dividends and buybacks. The latest FY2025 20-F and Q2 2026 filing do not point to securities-law enforcement issues against management, which lowers the “hidden governance blow-up” risk.

The main limitation is skin in the game. This is not a founder-led business, and insider ownership appears economically modest relative to the company’s size; that weakens owner-operator alignment. Still, incentive design matters more here than raw ownership: ASML’s pay structure has historically leaned heavily on long-term performance, which is sensible for a company whose value is created over multi-year product cycles and ecosystem trust.

Capital allocation is the strongest proof of orientation. ASML has consistently combined heavy reinvestment with substantial cash returns, rather than empire-building. That is exactly what minority holders should want from a near-monopoly tool supplier.

What I do not see is a recent insider-buying signal. Public materials retrieved here do not show meaningful open-market insider accumulation near today’s price, so this is aligned management, not conviction-signaling insider ownership.

Conclusion: ASML’s management looks elite on execution, disciplined on capital allocation, and notably candid; the main knock is that long-range targets can be buffeted by customer timing and export controls, not that management is promotional or sloppy.

Capital allocation has been shareholder-friendly and sensible: ASML has prioritized R&D and capacity, avoided large empire-building M&A, and returned excess cash through dividends and buybacks. That is the right playbook for a de facto monopoly with very high reinvestment returns. Execution is the stronger point: management has repeatedly delivered the EUV roadmap, scaled service revenue with the installed base, and, as of the July 15, 2026 6-K, raised 2026 guidance rather than walking it down. Transparency is also above average; filings openly discuss export controls, supply constraints, customer timing, and cyclicality.

On ethics/accounting, the latest 20-F shows a clean ICFR attestation and explicitly indicates no error-correction restatement. I do not see a disclosed pending litigation issue that looks thesis-breaking; the bigger risk remains geopolitics/regulation, not fraud or governance failure. Most recent filed data used: Q2 2026.

ASML is a superb business, but at a USD 717.23B market cap it looks expensive rather than investable on a 5–10 year return basis.

The right framework here is forward earnings power, not asset value. ASML’s Q2 2026 update raised full-year guidance to EUR 43-45B of sales and 54-56% gross margin, which is credible: management has already de-risked part of the year, and its backlog/installed-base economics are real. The problem is not quality; it is what is already in the price.

At today’s value, the market is effectively underwriting something like USD 20B+ of net income by 2031 and still paying ~28-30x earnings for it. That means investors need low-teens annual earnings growth for years after 2026 with no geopolitical or cyclical mishap. Possible? Yes. Cheap? No.

If management simply meets current 2026 goals, the stock does not look obviously mispriced on near-term numbers; the upside case requires ASML to grow well beyond the old long-range framework, or for the market to keep assigning an elite multiple indefinitely. My intrinsic value estimate is ~USD 560B, about 22% below today’s market cap.

Liquidation value is almost irrelevant here and very low versus price. Tangible book was roughly EUR 14.5B at FY2025, cash about EUR 12.9B, debt EUR 4.4B; after haircuts for specialized assets and working-capital frictions, equity recovery is probably only ~USD 15-20B.

Conclusion: ASML still looks like a rare long-duration compounder, but at this price the easy money is gone; the plausible outcome is roughly 2-3x in 10 years if EUV/High-NA remains the industry bottleneck and service revenue keeps compounding.

The moat should last a long time because it is not just a machine lead; it is a physics, supply-chain, software, process-integration, and installed-base monopoly. That is hard to replicate even with unlimited capital. Reinvestment still appears value-creative: R&D and field upgrades deepen customer dependence, while each new node makes lithography more central, not less. That is why returns on incremental capital have stayed unusually high despite ASML’s scale.

What erodes it first is not a normal competitor. It is a structural change in semiconductor scaling economics: if leading-edge customers stop needing more EUV intensity, or if packaging / design techniques reduce lithography’s strategic choke-point role, ASML’s reinvestment runway shortens.

Even under adverse conditions, ASML likely stays relevant in 10-20 years; the question is how dominant, not whether it survives.

Thesis-break signal: if leading-edge logic customers materially cut EUV and High-NA adoption plans for process reasons rather than cyclical reasons, and ASML’s service revenue growth decouples from the installed base, the long-term flywheel is weakening.

Conclusion: ASML’s risk profile is dominated by geopolitics, not economics. The core business still looks hard to disrupt; the main question is whether policy can durably weaken its China revenue, customer ecosystem, or innovation loop. Using data through Q2 2026.

The single biggest permanent risk is geopolitical escalation that structurally shrinks ASML’s addressable market or impairs cross-border semiconductor collaboration. That is plausible, but still not the base case. Most other “risks” are volatility sources, not thesis killers.

Final Verdict

TRACK. ASML is one of the best businesses in the world, but that does not make it a good stock at any price. At roughly USD 717230000000 of market cap and about 64.9x trailing earnings, the business quality is still elite while the expected return from here is not.

ASML remains an exceptional long-term compounder: dominant lithography position, monopoly-like economics in EUV, rising service revenue, strong returns on capital, and low balance-sheet risk. On business quality alone, it easily clears the bar for “ownable for 5-10 years.” The problem is simple: the valuation already prices in a lot of that greatness.

Your own base case is the key anchor: expected 2031 market cap of USD 560000000000 versus current USD 717230000000. By your framework, that rules out BUY. I agree. This is not a bad business; it is an expensive security.

The inversion case against this verdict is also clear: if AI-driven demand, advanced packaging, and High-NA adoption all exceed today’s already high expectations, ASML could still grow into the valuation and beyond. That is possible. It is just not the most probable outcome from today’s price.

For a new investor, the right move is wait, don’t chase. For an existing owner, the right answer is usually hold, not sell in panic: permanent business impairment risk is still low, and rare assets deserve patience. But I would not add aggressively here; at most, buy only in small tranches after material drawdowns.

Bottom line: exceptional business, modest permanent-capital-loss risk at the business level, but weak prospective returns at the current quote. Great company, wrong price.

What to research further

• High-NA order cadence and conversion into revenue
• China export-control downside vs non-China capacity offset
• Service gross-margin mix as installed base matures
• Whether AI demand is pulling forward foundry logic capex or structurally lifting it